100 related articles for article (PubMed ID: 1300779)
41. Renal tumors in rats given trisodium nitrilotriacetic acid in drinking water for 2 years.
Goyer RA; Falk HL; Hogan M; Feldman DD; Richter W
J Natl Cancer Inst; 1981 May; 66(5):869-80. PubMed ID: 6939931
[TBL] [Abstract][Full Text] [Related]
42. Comparative mutagenicities of bleomycin and ferric-nitrilotriacetate in lacZ mice.
Kosinska W; Pelle E; von Pressentin Md; Chen M; Guttenplan JB
Cancer Lett; 2002 Dec; 187(1-2):41-6. PubMed ID: 12359349
[TBL] [Abstract][Full Text] [Related]
43. Reversal of iron-induced nephrotoxicity in rats by molsidomine, a nitric oxide donor.
Gupta A; Sharma S; Chopra K
Food Chem Toxicol; 2008 Feb; 46(2):537-43. PubMed ID: 17935848
[TBL] [Abstract][Full Text] [Related]
44. Experimental iron overload using ferric nitrilotriacetate (Fe3+-NTA): a proposal model of the diseases in man caused by iron overload.
Awai M
Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1650-9. PubMed ID: 3564852
[No Abstract] [Full Text] [Related]
45. Nephrotoxicity and its prevention by vitamin E in ferric nitrilotriacetate-promoted lipid peroxidation.
Okada S; Hamazaki S; Ebina Y; Li JL; Midorikawa O
Biochim Biophys Acta; 1987 Oct; 922(1):28-33. PubMed ID: 3663701
[TBL] [Abstract][Full Text] [Related]
46. Sex differences in ferric nitrilotriacetate-induced lipid peroxidation and nephrotoxicity in mice.
Li JL; Okada S; Hamazaki S; Deng IL; Midorikawa O
Biochim Biophys Acta; 1988 Nov; 963(1):82-7. PubMed ID: 3179331
[TBL] [Abstract][Full Text] [Related]
47. Mechanism of iron toxicity in the liver and pancreas after a single injection of ferric nitrilotriacetate.
Yamanoi Y; Matsuura R; Awai M
Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1229-35. PubMed ID: 7168306
[No Abstract] [Full Text] [Related]
48. Effect of habitual exercise on renal carcinogenesis by ferric nitrilotriacetate.
Kato T; Kawaguchi H; Miyoshi N; Aoyama K; Komatsu M; Horiuchi M; Yoshida H; Takeuchi T
Environ Health Prev Med; 2011 Jul; 16(4):232-8. PubMed ID: 21431792
[TBL] [Abstract][Full Text] [Related]
49. [Nonepithelial tumors of rat kidneys induced by carcinogenic nitroso compounds].
Timoshenko IV; Tiutiunnik NF; Sherenesheva NI
Urol Nefrol (Mosk); 1977; (6):52-6. PubMed ID: 201071
[No Abstract] [Full Text] [Related]
50. Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway.
Liu YT; Shang D; Akatsuka S; Ohara H; Dutta KK; Mizushima K; Naito Y; Yoshikawa T; Izumiya M; Abe K; Nakagama H; Noguchi N; Toyokuni S
Am J Pathol; 2007 Dec; 171(6):1978-88. PubMed ID: 18055543
[TBL] [Abstract][Full Text] [Related]
51. Active oxygen species in DNA damage induced by carcinogenic metal compounds.
Kawanishi S; Inoue S; Yamamoto K
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):17-20. PubMed ID: 7843093
[TBL] [Abstract][Full Text] [Related]
52. Appearance of iron free hyperplastic hepatocytes following ferric nitrilotriacetate and 2-acetaminofluorene sequential administration.
Malvaldi G
Eur J Cancer (1965); 1981 Apr; 17(4):481-3. PubMed ID: 7308257
[No Abstract] [Full Text] [Related]
53. Effects of acute and sub-chronic administration of iron nitrilotriacetate in the rat.
Preece NE; Hall DE; Howarth JA; King LJ; Parke DV
Toxicology; 1989 Nov; 59(1):37-58. PubMed ID: 2573173
[TBL] [Abstract][Full Text] [Related]
54. Dose-related effect of trisodium nitrilotriacetate monohydrate on renal tumorigenesis initiated with N-ethyl-N-hydroxyethylnitrosamine in rats.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T
Carcinogenesis; 1985 Jun; 6(6):907-10. PubMed ID: 4006078
[TBL] [Abstract][Full Text] [Related]
55. The role of tubular iron accumulation in the remnant kidney.
Nankivell BJ; Chen J; Boadle RA; Harris DC
J Am Soc Nephrol; 1994 Feb; 4(8):1598-607. PubMed ID: 8025233
[TBL] [Abstract][Full Text] [Related]
56. Histogenesis of preneoplastic and neoplastic lesions of the kidney in rats ingesting N-4-(4'-fluorobiphenyl) acetamide.
Reuber MD
Pathol Microbiol (Basel); 1974; 41(5):266-74. PubMed ID: 4444834
[No Abstract] [Full Text] [Related]
57. The use of ferric nitrilotriacetate and ferrozine in iron transport studies.
Marx JJ
Eur J Clin Invest; 1995 Oct; 25(10):721. PubMed ID: 8557057
[No Abstract] [Full Text] [Related]
58. Ferric nitrilotriacetate: a potent stimulant of in vivo lipid peroxidation in mice.
Goddard JG; Sweeney GD
Biochem Pharmacol; 1983 Dec; 32(24):3879-82. PubMed ID: 6661264
[No Abstract] [Full Text] [Related]
59. Reversibility of renal cortical lesions induced in rats by high doses of nitrilotriacetate in chronic feeding studies.
Alden CL; Kanerva RL
Food Chem Toxicol; 1982 Dec; 20(6):935-7. PubMed ID: 6891678
[TBL] [Abstract][Full Text] [Related]
60. Influence of inorganic and organic iron compounds on parameters of cell growth and survival in human colon cells.
Klenow S; Pool-Zobel BL; Glei M
Toxicol In Vitro; 2009 Apr; 23(3):400-7. PubMed ID: 19444923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
